NeisVac-C is indicated for active immunisation in children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by Neisseria meningitidis serogroup C.
The use of NeisVac-C should be determined on the basis of official recommendations.
NeisVac-C will only confer protection against group C of Neisseria meningitidis and may not completely prevent meningococcal group C disease. It will not protect against other groups of Neisseria meningitidis or other organisms that cause meningitis or septicaemia.
There are no data on the use of NeisVac-C in adults aged 65 years or more.
Method of administration of NeisVac-C
NeisVac-C is for intramuscular injection, preferably in the anterolateral thigh region in infants and the deltoid region in older children, adolescents, and adults. In children 12 to 24 months of age, the vaccine may be administered in the deltoid or the anterolateral thigh.
Precautions to be taken before handling or administering the medicinal product.
The vaccine must not be administered subcutaneously or intravenously.
Please refer to the Summary of Product Characteristics for more information.
PP-NVC-GBR-0026. June 2018